Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says

Reuters | Paris | Updated: 26-01-2021 23:03 IST | Created: 26-01-2021 22:54 IST
Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
Representative image Image Credit: ANI

French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.

As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Addressing conflict-related sexual violence at long last

... ...

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Judge ends shooting case against Breonna Taylor's boyfriend

A judge in Kentucky has signed an order permanently closing a criminal case against Breonna Taylors boyfriend, who shot a police officer during the deadly raid that killed Taylor.Prosecutors dismissed an attempted murder of a police officer...

Once upon a time in Versailles: Dior conjures up edgy fashion fairytale

Christian Dior gave Little Red Riding Hood an edgy makeover for its latest collection on Monday, as it filled the runway with hooded capes and recreated a moonlit scene under the glinting chandeliers of the Versailles palaces Hall of Mirror...

Aviation industry urges Biden to back COVID-19 health credentials

Major U.S. aviation, travel and aerospace groups on Monday joined airline unions in urging the Biden administration to help establish temporary COVID-19 health credentials to boost travel, which has been hard-hit by the coronavirus pandemic...

Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.Blood taken...

Give Feedback